BioCentury
ARTICLE | Company News

OpGen, Merck deal

December 2, 2016 5:12 PM UTC

The companies partnered to develop diagnostics to detect antimicrobial resistance. Merck will provide OpGen access to its bacterial pathogens archive, and OpGen will perform genomic analysis, drug res...

BCIQ Company Profiles

Merck & Co. Inc.

OpGen Inc.